2-189110232-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000393.5(COL5A2):​c.315C>A​(p.Thr105Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.961 in 1,612,522 control chromosomes in the GnomAD database, including 746,605 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.93 ( 66285 hom., cov: 31)
Exomes 𝑓: 0.96 ( 680320 hom. )

Consequence

COL5A2
NM_000393.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.524

Publications

21 publications found
Variant links:
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
COL5A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, classic type, 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 2-189110232-G-T is Benign according to our data. Variant chr2-189110232-G-T is described in ClinVar as Benign. ClinVar VariationId is 439539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.524 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A2NM_000393.5 linkc.315C>A p.Thr105Thr synonymous_variant Exon 2 of 54 ENST00000374866.9 NP_000384.2 P05997
COL5A2XM_011510573.4 linkc.177C>A p.Thr59Thr synonymous_variant Exon 5 of 57 XP_011508875.1
COL5A2XM_047443251.1 linkc.177C>A p.Thr59Thr synonymous_variant Exon 7 of 59 XP_047299207.1
COL5A2XM_047443252.1 linkc.177C>A p.Thr59Thr synonymous_variant Exon 6 of 58 XP_047299208.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A2ENST00000374866.9 linkc.315C>A p.Thr105Thr synonymous_variant Exon 2 of 54 1 NM_000393.5 ENSP00000364000.3 P05997
COL5A2ENST00000649966.1 linkc.177C>A p.Thr59Thr synonymous_variant Exon 2 of 11 ENSP00000496785.1 A0A3B3IRH9
COL5A2ENST00000618828.1 linkc.-316C>A 5_prime_UTR_variant Exon 2 of 47 5 ENSP00000482184.1 A0A087WYX9

Frequencies

GnomAD3 genomes
AF:
0.931
AC:
141673
AN:
152098
Hom.:
66260
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.857
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.881
Gnomad ASJ
AF:
0.973
Gnomad EAS
AF:
0.906
Gnomad SAS
AF:
0.889
Gnomad FIN
AF:
0.990
Gnomad MID
AF:
0.962
Gnomad NFE
AF:
0.981
Gnomad OTH
AF:
0.931
GnomAD2 exomes
AF:
0.930
AC:
233806
AN:
251280
AF XY:
0.935
show subpopulations
Gnomad AFR exome
AF:
0.856
Gnomad AMR exome
AF:
0.799
Gnomad ASJ exome
AF:
0.969
Gnomad EAS exome
AF:
0.918
Gnomad FIN exome
AF:
0.988
Gnomad NFE exome
AF:
0.980
Gnomad OTH exome
AF:
0.943
GnomAD4 exome
AF:
0.964
AC:
1407881
AN:
1460306
Hom.:
680320
Cov.:
34
AF XY:
0.963
AC XY:
699557
AN XY:
726558
show subpopulations
African (AFR)
AF:
0.853
AC:
28528
AN:
33430
American (AMR)
AF:
0.805
AC:
36006
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.969
AC:
25326
AN:
26130
East Asian (EAS)
AF:
0.869
AC:
34478
AN:
39692
South Asian (SAS)
AF:
0.890
AC:
76703
AN:
86208
European-Finnish (FIN)
AF:
0.988
AC:
52796
AN:
53420
Middle Eastern (MID)
AF:
0.956
AC:
5329
AN:
5574
European-Non Finnish (NFE)
AF:
0.982
AC:
1091081
AN:
1110796
Other (OTH)
AF:
0.955
AC:
57634
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2552
5104
7655
10207
12759
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21600
43200
64800
86400
108000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.931
AC:
141747
AN:
152216
Hom.:
66285
Cov.:
31
AF XY:
0.931
AC XY:
69255
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.857
AC:
35561
AN:
41514
American (AMR)
AF:
0.880
AC:
13442
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.973
AC:
3377
AN:
3472
East Asian (EAS)
AF:
0.906
AC:
4686
AN:
5172
South Asian (SAS)
AF:
0.889
AC:
4286
AN:
4822
European-Finnish (FIN)
AF:
0.990
AC:
10513
AN:
10622
Middle Eastern (MID)
AF:
0.966
AC:
284
AN:
294
European-Non Finnish (NFE)
AF:
0.981
AC:
66721
AN:
68028
Other (OTH)
AF:
0.930
AC:
1965
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
469
937
1406
1874
2343
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.961
Hom.:
97947
Bravo
AF:
0.918
Asia WGS
AF:
0.897
AC:
3121
AN:
3478
EpiCase
AF:
0.979
EpiControl
AF:
0.976

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BA1 -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 2 Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
6.9
DANN
Benign
0.66
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4128539; hg19: chr2-189974958; COSMIC: COSV108216388; API